Drugs / Naropeine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT05969457 | Sep 2025 → Sep 2029 expected | — | University Hospital, Rouen | Recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT05848375 Comparator | Nov 2023 → Dec 2024 | rotator cuff syndrome | Elsan | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | naropeine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05848375 ↗ |
| Route | Other | “injecting anesthetic (between 10 and 20 ml of naropeine or chirocaine) into the interscalene nerve block under ultrasound guidance” NCT05848375 ↗ |